Kennedy Capital Management »

Intra Cellular Therapies shares owned by Kennedy Capital Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Kennedy Capital Management from 13F filings

Historical chart of Kennedy Capital Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Kennedy Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 27k 71.62
2023-09-30 $1.6M 30k 52.09
2023-06-30 $4.4M 70k 63.32
2023-03-31 $5.9M 108k 54.15
2022-12-31 $16M 309k 52.92
2022-09-30 $15M 324k 46.53
2022-06-30 $15M 253k 57.08
2022-03-31 $15M 241k 61.19
2021-12-31 $11M 205k 52.34
2021-09-30 $3.7M 98k 37.28